Kalehua Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Kalehua Capital Management LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $146.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$146.3M
| Company | Shares | Value |
|---|---|---|
| RLAYRelay Therapeutics, Inc. | 1,802,914 | $17.9M |
| SIONSionna Therapeutics, Inc. | 394,144 | $15.8M |
| MANEVeradermics Incorporated | 248,574 | $15.7M |
| ACRSAclaris Therapeutics, Inc. | 3,169,921 | $11.9M |
| ORKAOruka Therapeutics, Inc. | 237,048 | $11.6M |
| PHVSPharvaris N.V. | 397,544 | $11.2M |
| IKTInhibikase Therapeutics, Inc. | 6,494,498 | $10.9M |
| SEPNSepterna, Inc. | 389,088 | $9.3M |
| CMPSCOMPASS Pathways plc | 1,639,384 | $9.1M |
| QUREuniQure N.V. | 502,811 | $8.2M |
| DMRADamora Therapeutics, Inc. | 278,000 | $7.2M |
| MLTXMoonLake Immunotherapeutics | 351,468 | $6.6M |
| TYRATyra Biosciences, Inc. | 148,930 | $5.7M |
| PEPGPepGen Inc. | 1,729,961 | $3.1M |
| KRROKorro Bio, Inc. | 109,376 | $1.2M |
| DMACDiaMedica Therapeutics Inc. | 124,976 | $846K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.